Endocrinology and metabolism, 328(1), E116E125
Dehydroepiandrosterone protects against oleic acid-triggered mitochondrial dysfunction to relieve oxidative stress and inflammation via activation of the ampk-nrf2 axis by targeting gpr30 in hepatocytes
This size-based penetration advantage is central to its topical research applications and helps explain why laboratory studies have consistently demonstrated biological activity following topical application models
Studies show safe doses up to 2,000mg for NR and 1,200mg for NMN
Additional analyses have shown consistent results across most outcomes examined, which included a variety of cardiovascular diseases, such as incidence of atrial fibrillation, 239 coronary heart disease, incidence of hypertension, 216 and incidence of stroke, 71 diabetes, 240 chronic kidney disease, 222 mild cognitive impairment, Parkinsons disease, 241 and multiple sclerosis
2,6675,333 mcg of total blend once daily, titrated upward gradually across an 812 week course (about 1020 units )